c19
@c19ai
A Community of #Healthworkers #Scientists #Researchers #Humans Fighting #COVID19 with #AI
You might like
A suite of #AI driven #bioinformatics and #clinicalanalysis tools for the #healthcare and #scientific communities fighting #COVID-19. Join the movement 👉 c19.ai/?utm_source=tw…
28 year old recovering from #COVID-19 has to use an inhaler every couple minutes to reinvigorate her lungs. @CNN edition.cnn.com/2020/07/18/hea…
Blood type is not associated with a severe worsening of symptoms in people who have tested positive for #COVID19. @harvardmed hms.harvard.edu/news/covid-blo…
This study supports the use of #masks and airborne isolation precautions to protect from exposure to fine #SARSCoV2 aerosol when interacting with infected individuals, regardless of symptoms. medrxiv.org/content/10.110…
C19.ai is very excited to support thousands of @COVID19_NSVD's #scientists dedicated to fighting #COVID_19 with our suite of #AI driven #bioinformatics tools
Exciting news! C19.ai joins forces with @COVID19_NSVD to accelerate research for #COVID-19. Through collaborative research leveraged by #AI we can help end this #pandemic.
We are immensely proud to partner with you too @COVID19_NSVD to collectively reverse engineer #COVID_19 and help solve the world crisis
We are thrilled to announce that #NSVD has teamed up with @C19ai! This effort combines the power of #Scientists with the power of Artificial Intelligence to research #COVID19 c19.ai #EpiTwitter #AcademicTwitter #AI #FollowFriday
A compelling opportunity for #datascience to effectively multiply today’s #COVID19 testing capacity. @techreview #machinelearning #AI ow.ly/Uo9750AHF8v
Severe #COVID19 in 4 men in their 20's, from 2 families, with rare variants in TLR7 ( a loss-of-function tied to immune interferon defense). Cause and effect not proven, but very provocative report by @ahoischen and colleagues jamanetwork.com/journals/jama/… @JAMA_current via @pbleic
Wow!
Preprint reporting further evidence for the presence of #SARSCoV2 neutralising antibodies elicited by prior exposure to ‘common cold’ coronaviruses. Up to ~60% of healthy children/teenagers showed some cross-reactivity relative to ~6% of adults. biorxiv.org/content/10.110…
Immunogenicity and safety of a recombinant adenovirus type-5-vectored #COVID19 #vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial ow.ly/ZV2p50ADupv
Aging-associated inflammation—"inflammaging"—may worsen #COVID19 outcomes in older individuals. A new #SciMagPerspective discusses this possibility as well as strategies to mitigate related effects. Read more: fcld.ly/yqcvday
Potently neutralizing and protective human antibodies against SARS-CoV-2 nature.com/articles/s4158…
nature.com
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature - An analysis identifies human monoclonal antibodies that potently neutralize wild-type SARS-CoV-2 and protect animals from disease, including two that synergize in a cocktail, suggesting...
Interesting results provide important implications for continuing surveillance and interventions to eventually contain #COVID19 outbreaks. @nature #research ow.ly/Hv9F50ACwcK
⬇️👏🏽 Many of us, scientists, and other experts are willing to share our knowledge, time, expertise to help fight/end #COVID19 Pandemic. Reach out to us! We're here 👋🏽 #COVID19_NSVD
Looks like @EpiEllie called it! The likely reason deaths seemed to be falling was because the the lag between diagnosis and death got bigger due to more early testing. This is why data analysts need experts! We lost valuable time thinking we were doing better when we weren't!
The explosion of new #coronavirus tests that could help to end the #pandemic nature.com/articles/d4158…
Trials involving around 1,077 people showed the injection led to them making antibodies and white blood cells that can fight #coronavirus. @UniofOxford
Oxford’s Covid-19 vaccine produces a good immune response, reveals new study. Teams at @VaccineTrials and @OxfordVacGroup have found there were no safety concerns, and the vaccine stimulated strong immune responses: bit.ly/PhaseIResults
The reasons for worse #COVID19 outcomes in people with #diabetes also management requires a much-integrated team approach. @TheLancet thelancet.com/journals/landi…
#SARSCoV2 T cell immunity: Specificity, function, durability, and role in protection immunology.sciencemag.org/content/5/49/e…
Just out @ScienceMagazine: the importance of coordinated strategies in Europe for #COVID19 suppression, using mobility data science.sciencemag.org/content/sci/ea… "a resurgent continental epidemic could occur as many as 5 weeks earlier when...end their interventions prematurely" Sound familiar?
Impact of delays on effectiveness of contact tracing strategies for #COVID19: a modelling study @TheLancet thelancet.com/action/showPdf…
United States Trends
- 1. Deen N/A
- 2. Namjoon N/A
- 3. Mick Cronin N/A
- 4. #LCDLF6 N/A
- 5. Arizona State N/A
- 6. #River N/A
- 7. JT Toppin N/A
- 8. Tom Noonan N/A
- 9. Nebraska N/A
- 10. #YouTubeDOWN N/A
- 11. Iowa N/A
- 12. UCLA N/A
- 13. Pope N/A
- 14. Bobby Hurley N/A
- 15. Ramadan Mubarak N/A
- 16. Vini N/A
- 17. Lent N/A
- 18. Stirtz N/A
- 19. June Carter N/A
- 20. Landon N/A
Something went wrong.
Something went wrong.